Liposyn reports top-line safety and efficacy results for LPCN 1154 in patients with postpartum depression

(PRNewsfoto/Lipocine Inc.)

In a phase 3 study population of patients with PPD (N = 90), LPCN 1154 did not demonstrate a statistically significant reduction from baseline in the HAM-D17 total score at 60 hours (primary endpoint) compared to placebo. The primary endpoint was not met In a post hoc analysis of participants (n = 54) with a … Read more

Postpartum depression also affects fathers. We don’t just talk about it.

Postpartum depression also affects fathers. We don't just talk about it.

Recent decades have seen seismic changes in how we parent. Dads today are much more hands-on than their fathers or grandfathers – changing diapers in the middle of the night, working with story time, and taking precious maternity leave when they can. As I walk through Brooklyn, New York, I see many fathers playing with … Read more